Why Bernie Sanders May Be Best For Stock Market: Kaissar

Why Bernie Sanders May Be Best For Stock Market: Kaissar

Nir Kaissar, Founder of Unison Advisors and Bloomberg Opinion columnist, on why Bernie Sanders would be the best candidate for the U.S. stock market. Paul Brain, Head of Fixed Income for Newton Investment Management Ltd., discusses all things fixed income: global bonds, monetary policy, central banks, and green bonds. Noah Feldman, Harvard Law Professor and Bloomberg Opinion columnist, discusses his column: "Trump Has Hijacked Roger Stone’s Sentencing." Chris McCann, CEO of 1-800-FLOWERS.COM, Inc., to discuss Valentine’s Day business, online retail, and delivery. Hosted by Lisa Abramowicz and Paul Sweeney.

See omnystudio.com/listener for privacy information.

Episoder(3349)

Largest NY Hospital System Sees Return of Patients, Surgeries

Largest NY Hospital System Sees Return of Patients, Surgeries

Michael Dowling, President and CEO of Northwell Health, on how New York State’s largest hospital system is faring as the state begins reopening. Sarah Halzack, Bloomberg Opinion retail columnist, to d...

11 Jun 202029min

We're Looking At A Secular Shift To Lower Rates: PGIM's Tipp

We're Looking At A Secular Shift To Lower Rates: PGIM's Tipp

Robert Tipp, Chief Investment Strategist at PGIM, discusses fixed income markets and Fed stimulus. Jonathan Bernstein, Bloomberg Opinion politics columnist, on his column: "Be Ready for a Long Electio...

10 Jun 202027min

Why Military Leaders Like Me Are Speaking Out: James Stavridis

Why Military Leaders Like Me Are Speaking Out: James Stavridis

Retired Navy Admiral James Stavridis, former military commander of NATO and a Bloomberg Opinion columnist, discusses his column: "Why Military Leaders Like Me Are Speaking Out." Tara Lachapelle, Bloom...

9 Jun 202028min

Not Much Strategic Sense To An AstraZeneca-Gilead Deal

Not Much Strategic Sense To An AstraZeneca-Gilead Deal

Bloomberg Opinion's Max Nisen, biotech and health care columnist, and Chris Hughes, deals columnist, on AstraZeneca mulling a bid for Gilead. Bill Smead, CEO and CIO of Smead Capital Management, on bu...

8 Jun 202028min

Troubling Signs Lurk Within Shocking Job Gains: LaSalle CEO

Troubling Signs Lurk Within Shocking Job Gains: LaSalle CEO

Tom Gimbel, CEO of global staffing company LaSalle Network, dissects the unexpectedly strong jobs report. Danielle DiMartino Booth, CEO and Chief Strategist at Quill Intelligence LLC, Bloomberg Opinio...

5 Jun 202034min

A Real Leader Is Needed To Deliver Vital Changes: David McCourt

A Real Leader Is Needed To Deliver Vital Changes: David McCourt

David McCourt, Founder and CEO of Granahan McCourt Capital and Chairman of National Broadband Ireland, discusses the need for a great leader in times of crisis. Mary Schlangenstein, U.S. Airlines Repo...

4 Jun 202029min

Yes, Trump Can Send In The Military But Probably Won't: Feldman

Yes, Trump Can Send In The Military But Probably Won't: Feldman

Noah Feldman, Harvard Law professor and Bloomberg Opinion columnist, discusses his column: "Can Trump Send In the Military? Probably, Yes." Yelena Shulyatyeva, Senior U.S. Economist for Bloomberg Econ...

3 Jun 202029min

It's A Borrower's Bond Market, As Amazon Scores Record Low Rates.

It's A Borrower's Bond Market, As Amazon Scores Record Low Rates.

Molly Smith, corporate finance reporter for Bloomberg, on why it's a borrower's bond market. John Streur, CEO of Calvert Research and Management, discusses why ending racism in America is a responsibi...

2 Jun 202029min

Populært innen Business og økonomi

stopp-verden
lydartikler-fra-aftenposten
dine-penger-pengeradet
rss-penger-polser-og-politikk
e24-podden
rss-borsmorgen-okonominyhetene
pengepodden-2
finansredaksjonen
utbytte
livet-pa-veien-med-jan-erik-larssen
rss-sunn-okonomi
pengesnakk
tid-er-penger-en-podcast-med-peter-warren
morgenkaffen-med-finansavisen
okonomiamatorene
stormkast-med-valebrokk-stordalen
lederpodden
liberal-halvtime
rss-markedspuls-2
lederskap-nhhs-podkast-om-ledelse